Literature DB >> 1915503

Effects of dopamine infusion on plasma catecholamines in preterm and term newborn infants.

H Stopfkuchen1, K Racké, H Schwörer, A Queisser-Luft, K Vogel.   

Abstract

Newborn infants (21 preterm and 13 term) received dopamine infusions at a low (2.5-3.4 micrograms/kg per min) and/or high (5-10 micrograms/kg per min) infusion rate and changes in plasma catecholamines were monitored. The mean baseline values for dopamine, noradrenaline and adrenaline were between 240 and 560, 125 and 144 and 62 and 82 pg/ml, respectively. During low-rate infusion of dopamine, there was a significant increase in plasma dopamine (20-100 fold), noradrenaline (three- to five-fold) and adrenaline (threefold). Administration of dopamine at the high rate resulted in an even larger increase in the plasma catecholamines (dopamine, 100-300 fold; noradrenaline, seven- to eightfold; adrenaline, four- to sixfold). In a double-log plot, there was a highly significant correlation between the plasma concentrations of dopamine and noradrenaline (r = 0.77; P less than 0.001). In conclusion, infusion of dopamine in term and preterm newborn infants is accompanied by an enhanced sympatho-adrenal tone which may contribute to the cardiovascular effects of dopamine in these patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1915503     DOI: 10.1007/bf01958433

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  16 in total

1.  Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart.

Authors:  J D Port; E M Gilbert; P Larrabee; P Mealey; K Volkman; R Ginsburg; R E Hershberger; J Murray; M R Bristow
Journal:  Circulation       Date:  1990-03       Impact factor: 29.690

Review 2.  The use of inotropic and afterload-reducing agents in neonates.

Authors:  S R Keeley; D J Bohn
Journal:  Clin Perinatol       Date:  1988-09       Impact factor: 3.430

3.  Release of tritiated noradrenaline from perfused rat hearts by sympathomimetic amines.

Authors:  C W Nash; S A Wolff; B A Ferguson
Journal:  Can J Physiol Pharmacol       Date:  1968-01       Impact factor: 2.273

4.  Dobutamine: development of a new catecholamine to selectively increase cardiac contractility.

Authors:  R R Tuttle; J Mills
Journal:  Circ Res       Date:  1975-01       Impact factor: 17.367

5.  Correlation between the pharmacokinetics and pharmacodynamics of dopamine in healthy subjects.

Authors:  U Gundert-Remy; J Penzien; R Hildebrandt; W Mäurer; E Weber
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Inotropic response of the neonatal canine myocardium to dopamine.

Authors:  D J Driscoll; P C Gillette; E G Ezrailson; A Schwartz
Journal:  Pediatr Res       Date:  1978-01       Impact factor: 3.756

7.  Release of endogenous 3,4-dihydroxyphenylethylamine and its metabolites from the isolated neurointermediate lobe of the rat pituitary gland. Effects of electrical stimulation and of inhibition of monoamine oxidase and reuptake.

Authors:  K Racké; E Muscholl
Journal:  J Neurochem       Date:  1986-03       Impact factor: 5.372

8.  Dopamine pharmacokinetics in critically ill newborn infants.

Authors:  J F Padbury; Y Agata; B G Baylen; J K Ludlow; D H Polk; E Goldblatt; J Pescetti
Journal:  J Pediatr       Date:  1987-02       Impact factor: 4.406

9.  Influence of dobutamine and dopamine on hemodynamics and plasma concentrations of noradrenaline and renin in patients with low cardiac output following acute myocardial infarction.

Authors:  T L Kho; J W Henquet; R Punt; W H Birkenhäger; K H Rahn
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

10.  Comparative hemodynamic effects of isoproterenol, dopamine, and dobutamine in the newborn dog.

Authors:  D J Driscoll; P C Gillette; R M Lewis; C J Hartley; A Schwartz
Journal:  Pediatr Res       Date:  1979-09       Impact factor: 3.756

View more
  5 in total

1.  Randomised controlled trial evaluating effects of morphine on plasma adrenaline/noradrenaline concentrations in newborns.

Authors:  S H P Simons; M van Dijk; R A van Lingen; D Roofthooft; F Boomsma; J N van den Anker; D Tibboel
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-01       Impact factor: 5.747

2.  Stress, severity of illness, and outcome in ventilated preterm infants.

Authors:  D P Barker; N Rutter
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-11       Impact factor: 5.747

3.  Neonatal catecholamine levels and neurodevelopmental outcome: a cohort study.

Authors:  D J Evans; R J MacGregor; H G Dean; M I Levene
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-01       Impact factor: 5.747

4.  Randomised, double blind trial of two loading dose regimens of diamorphine in ventilated newborn infants.

Authors:  D P Barker; J Simpson; M Pawula; D A Barrett; P N Shaw; N Rutter
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-07       Impact factor: 5.747

Review 5.  Inotropes for Preterm Infants: 50 Years on Are We Any Wiser?

Authors:  Aisling A Garvey; Elisabeth M W Kooi; Eugene M Dempsey
Journal:  Front Pediatr       Date:  2018-04-06       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.